Date:
Location:
A part of the HUBweek series of events.
Hear from leading scientists, clinicians, and executives at HSCI and partner institutions who are working toward bringing stem cell-derived therapies to diabetic patients through the Boston Autologous Islet Replacement Therapy (BAIRT) Program.
Moderator: Carey Goldberg, WBUR
Doug A. Melton, PhD
Xander University Professor and Thomas Dudley Cabot Professor in the Natural Sciences, Harvard University
Co-Director, Harvard Stem Cell Institute
Scientific Founder, Semma Therapeutics
Sayeed Malek, MD
Clinical Director, Division of Transplant Surgery, Brigham & Women’s Hospital
Peter S. Amenta, MD, PhD
President and CEO, Joslin Diabetes Center
Robert Millman, JD
CEO, Semma Therapeutics
Gordon C. Weir, MD
Co-Head, Section on Islet Cell & Regenerative Biology
Diabetes Research and Wellness Foundation Chair, Joslin Diabetes Center
Professor of Medicine, Harvard Medical School
Program is offered free of charge to the general public, but registration is required at:
https://www.eventbrite.com/e/horizons-in-regenerative-medicine-a-quantum-leap-in-diabetes-treatment-tickets-26574743774#tickets